Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Taiwan · Delayed Price · Currency is TWD

395.00

-5.00 (-1.25%)

Sep 24, 2026, 1:30 PM CST

Market Cap	21.51B -3.9%
Revenue (ttm)	2.19B +12.5%
Net Income	811.53M +16.1%
EPS	14.88 +16.1%
Shares Out	54.46M
PE Ratio	26.55
Forward PE	n/a
Dividend	12.10 (3.06%)
Ex-Dividend Date	Mar 31, 2026

Volume	43,016
Open	399.00
Previous Close	400.00
Day's Range	391.50 - 399.00
52-Week Range	350.00 - 429.00
Beta	-0.12
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 11, 2026

About Sunmax Biotechnology

Sunmax Biotechnology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally. It offers collagen dermal filler sets, such as Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO injectable collagen gel with lidocaine. The company was founded in 2001 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2001

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 4728

Full Company Profile

Financial Performance

In 2025, Sunmax Biotechnology's revenue was 2.03 billion, an increase of 11.45% compared to the previous year's 1.82 billion. Earnings were 725.75 million, an increase of 6.82%.

Financial Statements